Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

762 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[No title available]
[No authors listed] [No authors listed] PMID: 37785135
[No title available]
[No authors listed] [No authors listed] PMID: 37785136
[No title available]
[No authors listed] [No authors listed] PMID: 37785007
[No title available]
[No authors listed] [No authors listed] PMID: 37785061
[No title available]
[No authors listed] [No authors listed] PMID: 37785090
[No title available]
[No authors listed] [No authors listed] PMID: 37785197
Novel echocardiographic pixel intensity quantification method for differentiating transthyretin cardiac amyloidosis from light chain cardiac amyloidosis and other phenocopies.
Slostad B, Appadurai V, Narang A, Hale S, Lehrer S, Bavishi A, Kline A, Okwuosa I, Jankowski M, Weinberg R, Kansal M, Thomas JD, Shah S. Slostad B, et al. Among authors: narang a. Eur Heart J Cardiovasc Imaging. 2024 Apr 6:jeae095. doi: 10.1093/ehjci/jeae095. Online ahead of print. Eur Heart J Cardiovasc Imaging. 2024. PMID: 38581424
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.
Gebrael G, Jo Y, Mathew Thomas V, Li H, Sayegh N, Tripathi N, Srivastava A, Nordblad B, Dal E, Narang A, Brundage J, Campbell P, Galarza Fortuna G, Hage Chehade C, Maughan BL, Agarwal N, Swami U. Gebrael G, et al. Among authors: narang a. Cancer. 2024 Apr 2. doi: 10.1002/cncr.35302. Online ahead of print. Cancer. 2024. PMID: 38564301
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting.
Gebrael G, Hage Chehade C, Sayegh N, Tripathi N, Chigarira B, Goel D, Nordblad B, McFarland TR, Narang A, Srivastava A, Tandar C, Dal E, Jo Y, Galarza Fortuna G, Mathew Thomas V, Sahu KK, Li H, Maughan BL, Swami U, Agarwal N. Gebrael G, et al. Among authors: narang a. Prostate. 2024 Apr 1. doi: 10.1002/pros.24696. Online ahead of print. Prostate. 2024. PMID: 38561317
762 results